Abbreviations
In this guide
In this guide|
ADI |
Acceptable daily intake |
|
ALP |
Alkaline phosphatase |
|
ALT |
Alanine aminotransferase |
|
AST |
Aspartate aminotransferase |
|
AUC |
Area under the curve |
|
BMDL10 |
Benchmark dose lower confidence limit for 10% above background |
|
BMDU10 |
Benchmark dose upper confidence limit for 10% above background |
|
Cmax |
Maximum concentration |
|
DILI |
Drug-induced liver injury |
|
DSILI |
Dietary supplement-induced liver injury |
|
EFSA ANS |
Panel on Food Additives and Nutrient Sources Added to Food |
|
EGCG |
(-)- Epigallocatechin-3-gallate |
|
EMA |
European Medicines Agency |
|
ESCO |
EFSA Scientific Cooperation |
|
GTC |
Green tea catechin |
|
GTE |
Green tea extract |
|
HILI |
Herb-induced liver injury |
|
IARC |
International Agency for Research on Cancer |
|
IDILI |
Idiosyncratic drug-induced liver injury |
|
i.p. |
intraperitoneal |
|
LOQ |
Limit of quantification |
|
NIH |
National Institutes of Health |
|
NOAEL |
No-observed-adverse-effect level |
|
PA |
Pyrrolizidine alkaloids |
|
US FDA |
United States Food and Drug Administration |
|
USP-NF |
United States Pharmacopeia National Formulary |